Journal of Vascular Surgery
Volume 50, Issue 6 , Pages 1444-1451 , December 2009

DNA-array of gene variants in venous leg ulcers: Detection of prognostic indicators

  • Donato Gemmati, PhD

      Affiliations

    • Haemostasis & Thrombosis Center, University of Ferrara, Ferrara, Italy
    • Vascular Disease Center, University of Ferrara, Ferrara, Italy
    • Corresponding Author InformationReprint requests: Donato Gemmati, PhD, Haemostasis & Thrombosis Center, Biomedical Sciences & Advanced Therapies, Unit of Haematology, University of Ferrara, C. So Giovecca 203, I-44100 Ferrara, Italy
    • ,
  • Federica Federici, PhD

      Affiliations

    • Haemostasis & Thrombosis Center, University of Ferrara, Ferrara, Italy
    • Vascular Disease Center, University of Ferrara, Ferrara, Italy
    • ,
  • Linda Catozzi, PhD

      Affiliations

    • Haemostasis & Thrombosis Center, University of Ferrara, Ferrara, Italy
    • Vascular Disease Center, University of Ferrara, Ferrara, Italy
    • ,
  • Sergio Gianesini, MD

      Affiliations

    • Vascular Disease Center, University of Ferrara, Ferrara, Italy
    • ,
  • Giovanna Tacconi, MD

      Affiliations

    • Vascular Disease Center, University of Ferrara, Ferrara, Italy
    • ,
  • Gian L. Scapoli, MD

      Affiliations

    • Haemostasis & Thrombosis Center, University of Ferrara, Ferrara, Italy
    • Vascular Disease Center, University of Ferrara, Ferrara, Italy
    • ,
  • Paolo Zamboni, MD

      Affiliations

    • Vascular Disease Center, University of Ferrara, Ferrara, Italy

Received 6 February 2009 ,Accepted 25 July 2009.

References 

  1. Bergqvist D, Lindholm C, Nelzén O. Chronic leg ulcers: the impact of venous disease. J Vasc Surg. 1999;29:752–755
  2. Abbade LP, Lastória S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol. 2005;44:449–456
  3. McGuckin M, Waterman R, Brooks J, Cherry G, Porten L, Hurley S, et al. Validation of venous leg ulcer guidelines in the United States and United Kingdom. Am J Surg. 2002;183:132–137
  4. Abbade LP, Lastória S, de Almeida Rollo H, Stolf HO. A sociodemographic, clinical study of patients with venous ulcer. Int J Dermatol. 2005;44:989–992
  5. Cesarone MR, Belcaro G, Nicolaides AN, Geroulakos G, Griffin M, Incandela L, et al. 'Real' epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project. Angiology. 2002;53:119–130
  6. Gohel MS, Taylor M, Earnshaw JJ, Heather BP, Poskitt KR, Whyman MR. Risk factors for delayed healing and recurrence of chronic venous leg ulcers—an analysis of 1324 legs. Eur J Vasc Endovasc Surg. 2005;29:74–77
  7. Charles CA, Tomic-Canic M, Vincek V, Nassiri M, Stojadinovic O, Eaglstein WH, et al. A gene signature of nonhealing venous ulcers: potential diagnostic markers. J Am Acad Dermatol. 2008;59:758–771
  8. Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006;99:589–593
  9. Simka M, Rybak Z. Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions. Med Hypotheses. 2008;71:293–297
  10. Ashworth JJ, Smyth JV, Pendleton N, Horan M, Payton A, Worthington J, et al. The dinucleotide (CA) repeat polymorphism of estrogen receptor beta but not the dinucleotide (TA) repeat polymorphism of estrogen receptor alpha is associated with venous ulceration. J Steroid Biochem Mol Biol. 2005;97:266–270
  11. Nagy N, Szolnoky G, Szabad G, Bata-Csörgo Z, Dobozy A, Kemeny L, et al. Single nucleotide polymorphisms of the fibroblast growth factor receptor 2 gene in patients with chronic venous insufficiency with leg ulcer. J Invest Dermatol. 2005;124:1085–1088
  12. Wallace HJ, Vandongen YK, Stacey MC. Tumor necrosis factor-alpha gene polymorphism associated with increased susceptibility to venous leg ulceration. J Invest Dermatol. 2006;126:921–925
  13. Ashworth JJ, Smyth JV, Pendleton N, Horan M, Payton A, Worthington J, et al. Polymorphisms spanning the 0N exon and promoter of the estrogen receptor-beta (ERbeta) gene ESR2 are associated with venous ulceration. Clin Genet. 2008;73:55–61
  14. Zamboni P, Tognazzo S, Izzo M, Pancaldi F, Scapoli GL, Liboni A, et al. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg. 2005;42:309–314
  15. Zamboni P, Izzo M, Tognazzo S, Carandina S, De Palma M, Catozzi L, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med. 2006;40:1869–1873
  16. Zamboni P, Scapoli G, Lanzara V, Izzo M, Fortini P, Legnaro R, et al. Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg. 2005;31:644–649discussion 649
  17. Gemmati D, Tognazzo S, Catozzi L, Federici F, De Palma M, Gianesini S, et al. Influence of gene polymorphisms in ulcer healing process after superficial venous surgery. J Vasc Surg. 2006;44:554–562
  18. Tognazzo S, Gemmati D, Palazzo A, Catozzi L, Carandina S, Legnaro A, et al. Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers. J Vasc Surg. 2006;44:815–819
  19. Zamboni P, De Mattei M, Ongaro A, Fogato L, Carandina S, De Palma M, et al. Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells. Vasc Endovascular Surg. 2004;38:431–438
  20. Gemmati D, Tognazzo S, Serino ML, Fogato L, Carandina S, De Palma M, et al. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension. Wound Repair Regen. 2004;12:512–517
  21. Zamboni P, Gemmati D. Clinical implications of gene polymorphisms in venous leg ulcer: a model in tissue injury and reparative process. Thromb Haemost. 2007;98:131–137
  22. Zamboni P. Genetics of venous leg ulcer: an indication to priority of varicose veins treatment?. Int Angiol. 2008;27:91–92
  23. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403:776–781
  24. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299–309
  25. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000;275:19906–19912
  26. De Domenico I, Ward DM, Musci G, Kaplan J. Iron overload due to mutations in ferroportin. Haematologica. 2006;91:92–95
  27. Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem. 1993;268:23824–23829
  28. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2008;75:346–359
  29. Jormsjö S, Ye S, Moritz J, Walter DH, Dimmeler S, Zeiher AM, et al. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res. 2000;86:998–1003
  30. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol. 2002;40:43–48
  31. Borghese B, Chiche JD, Vernerey D, Chenot C, Mir O, Bijaoui G, et al. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression. Hum Reprod. 2008;23:1207–1213
  32. Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, et al. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis. 2006;27:1024–1029
  33. Zamboni P, Cisno C, Marchetti F, Mazza P, Fogato L, Carandina S, et al. Minimally invasive surgical management of primary venous ulcers vs. compression treatment: a randomized clinical trial. Eur J Vasc Endovasc Surg. 2003;25:313–318
  34. Nicolaides AN. Investigation of chronic venous insufficiency: a consensus statement (France, March 5-9, 1997). Circulation. 2000;102:E126–E163
  35. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–1252
  36. Ferrari M, Cremonesi L, Bonini P, Foglieni B, Stenirri S. Single-nucleotide polymorphism and mutation identification by the nanogen microelectronic chip technology. Methods Mol Med. 2005;114:93–106
  37. Sosnowski R, Heller MJ, Tu E, Forster AH, Radtkey R. Active microelectronic array system for DNA hybridization, genotyping and pharmacogenomic applications. Psychiatr Genet. 2002;12:181–192
  38. McCune CA, Ravine D, Worwood M, Jackson HA, Evans HM, Hutton D. Screening for hereditary haemochromatosis within families and beyond. Lancet. 2003;362:1897–1898
  39. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G—> A (C282Y) HFE hereditary haemochromatosis mutation in USA. Lancet. 2002;359:211–218
  40. Lee P, Gelbart T, West C, Halloran C, Beutler E. Seeking candidate mutations that affect iron homeostasis. Blood Cells Mol Dis. 2002;29:471–487
  41. Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, Edwards JP, et al. Resistance hepcidin is conferred by hemochromatosis-associated mutations ferroportin. Blood. 2005;106:1092–1097
  42. Drakesmith H, Sweetland E, Schimanski L, Edwards J, Cowley Ashraf M, et al. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc Natl Acad Sci U S A. 2002;99:15602–15607
  43. Moura E, Noordermeer MA, Verhoeven N, Verheul AF, Marx JJ. Iron release from human monocytes after erythrophagocytosis vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood. 1998;92:2511–2519
  44. Tavaré JM, Rutter GA, Griffiths MR, Dobson SP, Gray H. Regulation of gene expression by insulin: analysis in single living cells. Biochem Soc Trans. 1996;24:378–384
  45. Gemmati D, Federici F, Campo G, Tognazzo S, Serino ML, De Mattei M, et al. Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. Mol Med. 2007;13:112–120
  46. Lanzara S, Catozzi L, De Palma M, Federici F, Palazzo A, Tacconi G, et al. The inflammatory chain in chronic venous leg ulcer. Acta Phlebol. 2006;7:39–44

 This study was supported in part by funds from MIUR (the Italian Ministry for University Instruction and Research) and thanks to a grant from Fondazione Cassa di Risparmio - Cento, Italy.

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01576-6

doi: 10.1016/j.jvs.2009.07.103

Journal of Vascular Surgery
Volume 50, Issue 6 , Pages 1444-1451 , December 2009

Article Tools

* Image Usage & Resolution